The IPO raised $8 million, and was three times oversubscribed.
THC will generate immediate cash flow through its equipment division - a proven, long-term, profitable business with over 600 products and strong distribution networks in the U.S, Canada, U.K. and Europe.
Funds will be used to expand THC’s market share as a key manufacturer and distributor of hydroponics equipment, materials and related services.
Find out more from Andrew Beehag at Proactive's CEO Sessions.
Click below to register by email
- Paradigm Biopharmaceuticals (ASX:PAR): CEO Paul Rennie
- Stonewall Resources (ASX:SWJ): MD Robert Thomson
- White Rock Minerals (ASX:WRM): MD Matthew Gill
- The Hydroponics Company (ASX:THC): CEO (medicinal Cannabis division, Canndeo) Andrew Beehag
More companies to be added to the roster...